Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
02/1998
02/26/1998WO1998007400A1 Transdermal propentofylline compositions for the treatment of alzheimer's disease
02/26/1998WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase
02/26/1998WO1997039123A3 Secreted proteins
02/26/1998CA2268051A1 Neuropeptide-y ligands
02/26/1998CA2264192A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2264064A1 Imidazole compounds, compositions and use
02/26/1998CA2263875A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2263149A1 Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes
02/26/1998CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
02/26/1998CA2259515A1 Troponyl piperazines as selective dopamine d4 receptor ligands
02/26/1998CA2255966A1 Non-peptide bombesin receptor antagonists
02/26/1998CA2255580A1 Transdermal propentofylline compositions for the treatment of alzheimer's disease
02/25/1998EP0825193A1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
02/25/1998EP0825180A1 1-omega-(3,4-dihydro-2-naphthalenyl)alkyl] cyclic amine derivatives, process for producing the same, and medicinal composition containing the same
02/25/1998EP0825178A1 Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them
02/25/1998EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque
02/25/1998EP0824544A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
02/25/1998EP0824543A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
02/25/1998EP0824538A1 Saccharopeptides and derivatives thereof
02/25/1998EP0824530A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
02/25/1998EP0824519A1 Beta-adrenergic agonists
02/25/1998EP0824356A1 Pharmaceutical compositions for the treatment of alcohol addiction
02/25/1998EP0702673B1 Benz(b)azepine-2,5-diones useful in the treatment of neurodegenerative disorders
02/25/1998EP0697019B1 Risperidone pamoate
02/25/1998CN1174505A Pharmaceutical composition comprising lamotrigine
02/25/1998CN1174079A Medicine for abstaining from drugs and its preparation
02/25/1998CN1037510C Prep. of indole derivatives
02/24/1998US5721356 Orally active adenosine kinase inhibitors
02/24/1998US5721276 Treating disorders of melatoninergic system
02/24/1998US5721260 Heterocyclic compounds
02/24/1998US5721258 Antagonist of n-methyl-d-aspartate
02/24/1998US5721256 Inhibitors of the enzyme activity associated with immunophilin proteins
02/24/1998US5721255 Useful for preventing pain, anxiety, migrane, schizophrenia, asthma, rheumatoid arthritis, fibrositis, or ulcerative colitis in mammal
02/24/1998US5721254 Antiinflammatory agents; analgesics
02/24/1998US5721252 5HT1F agonists for the treatment of migraine
02/24/1998US5721249 Administering to treat angina
02/24/1998US5721247 Neurodegenerative disorders
02/24/1998US5721243 Anticholinergic agents
02/24/1998US5721215 Injectable therapy for control of muscle spasms and pain related to muscle spasms
02/24/1998US5720975 Use of incense in the treatment of alzheimer's disease
02/24/1998US5720974 Compression molding mixture of active material, carbohydrate and water
02/24/1998CA2043071C Heterocyclic compounds
02/23/1998CA2183901A1 Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans
02/21/1998CA2213361A1 Stable, long acting salts of carboxamides for the treatment of joint disease
02/19/1998WO1998006847A1 Human dbi/acbp-like protein
02/19/1998WO1998006846A1 Human induced tumor protein
02/19/1998WO1998006841A2 Two human nsp-like proteins
02/19/1998WO1998006840A1 Novel human glycoprotein
02/19/1998WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses
02/19/1998WO1998006716A1 Preparation of aminomethyl-phenylimidazoles
02/19/1998WO1998006711A1 Butyric acid matrix metalloproteinase inhibitors
02/19/1998WO1998006708A1 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
02/19/1998WO1998006701A1 Il-8 receptor antagonists
02/19/1998WO1998006699A1 Tetrahydroisoquinoline derivatives and their pharmaceutical use
02/19/1998WO1998006697A1 Ether muscarinic antagonists
02/19/1998WO1998006690A1 USE OF η-HYDROXYBUTYRIC ACID AMIDES IN THE TREATMENT OF DRUG ADDICTION AND IN PARTICULAR OF ALCOHOLISM
02/19/1998WO1998006417A1 Methods to treat cerebral ischemic injury and other neuronal diseases
02/19/1998WO1998006403A1 Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
02/19/1998WO1998006401A1 Pharmaceutically active compounds and methods of use
02/19/1998WO1998006399A1 Il-8 receptor antagonists
02/19/1998WO1998006392A1 Formulation of 5-ht agonists
02/19/1998WO1998006262A1 Il-8 receptor antagonists
02/19/1998WO1998001124A3 Pharmaceutical preparation containing nimesulide for topical use
02/19/1998WO1997044356A3 Ret ligand (retl) for stimulating neural and renal growth
02/19/1998CA2264104A1 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
02/19/1998CA2263284A1 Tetrahydroisoquinoline derivatives and their pharmaceutical use
02/19/1998CA2263172A1 Two human nsp-like proteins
02/19/1998CA2263169A1 Human dbi/acbp-like protein
02/19/1998CA2263165A1 Human induced tumor protein
02/19/1998CA2263100A1 Pharmaceutically active compounds and methods of use
02/19/1998CA2261752A1 Preparation of aminomethyl-phenylimidazoles
02/19/1998CA2261130A1 Methods to treat cerebral ischemic injury and other neuronal diseases
02/18/1998EP0824098A1 4-hydroxy-piperidine derivatives
02/18/1998EP0823909A1 Novel heterocyclic chemistry
02/18/1998EP0823906A1 Piperazino derivatives as neurokinin antagonists
02/18/1998EP0823905A1 Novel heterocyclic chemistry
02/18/1998EP0823896A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
02/18/1998EP0823895A1 Fatty acid esters as bioactive compounds
02/18/1998EP0823892A1 Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma
02/18/1998EP0823889A1 1,3-propane diol derivatives as bioactive compounds
02/18/1998CN1173864A Sulfamate compounds containing n -substituted carbanoyl and process for preparing the same
02/18/1998CN1173818A Pharmaceutical preparations for tumour necrosis factor (TNF) inhibition
02/18/1998CN1173344A Effective medicine composition for treatment of rheumatism and its capsule
02/18/1998CN1173330A Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitiors
02/18/1998CN1173329A Health Vitamin B6 Cigarette Plaster and its prepn. method
02/18/1998CN1037443C Method of prepn. of phosostigmine carbamate derivatives from physostigmine
02/18/1998CN1037439C Method for prepn. fo neuroprotective indolone and related derivatives
02/18/1998CN1037438C Method for prepn. of chroman and thiochroman derivatives
02/17/1998US5719286 Optical pure chemical intermediates
02/17/1998US5719279 Cholinomimetics
02/17/1998US5719278 Tricyclic benzazepine vasopressin antagonists
02/17/1998US5719191 Administering 1,1,2-triphenylbut-1-ene derivatives
02/17/1998US5719187 Compounds having a guanidine structure and pharmaceutical composition containing same
02/17/1998US5719186 Central muscle relaxants, anxiolytic agents, antiinflammatory agents, analgesics, anticonvulsants
02/17/1998US5719185 Use for GABA agonists for treating emesis
02/17/1998US5719181 Treatment of central nervous system disorders
02/17/1998US5719175 Protein kinase C inhibitors
02/17/1998US5719169 Substituted benzoylguanidines, their use as a medicament or diagnostic, and medicament containing them
02/17/1998US5719168 Acetamide derivatives and their use as feeding behaviour modifiers
02/17/1998US5719166 Treating psychoses